Iridex to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021

MOUNTAIN VIEW, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Iridex CorporationA (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the fourth quarter and full year of 2020 after the close of trading on Monday, March 22, 2021. The Companya??s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for international callers, using conference ID: 1137827. A live and archived webcast of the event will be available on the a??Investorsa?? section of the Companya??s website at: Iridex
IridexA is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Companya??s proprietaryA MicroPulseA technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.A Iridexa??s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases.A IridexA products are sold inA theA United StatesA andA GermanyA through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visitA Relations Contact:
Leigh Salvo
(415) 937-5404
investors@iridex.comMedia Contact:
Jamie Hall
Pascale Communications, LLC.
(724) 417-0167

Iridex to Report Fourth Quarter and Full Year 2020 Financial Results on March 22, 2021
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Апрель 2021    »